Coronavirus: Commission approves new contract for a potential COVID-19 vaccine with Novavax
The European Commission yesterday approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022.
Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses over the course of 2021, 2022, and 2023, once reviewed and approved by EMA as safe and effective. Member States will also be able to donate vaccines to lower and middle-income countries or to re-direct them to other European countries.
Yesterday's contract complements an already broad portfolio of vaccines to be produced in Europe, including the contracts with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna and the concluded exploratory talks with Valneva. It represents another key step towards ensuring that Europe is well prepared to face the COVID-19 pandemic.
The President of the European Commission, Ursula von der Leyen, yesterday said:
“As new coronavirus variants are spreading in Europe and around the world, this new contract with a company that is already testing its vaccine successfully against these variants is an additional safeguard for the protection of our population. It further strengthens our broad vaccine portfolio, to the benefit of Europeans and our partners worldwide.”
Stella Kyriakides, Commissioner for Health and Food Safety, yesterday said:
“Vaccinations in the EU are advancing and we are closer to our target of 70% fully vaccinated citizens by the end of summer. Our new agreement with Novavax expands our vaccine portfolio to include one more protein-based vaccine, a platform showing promise in clinical trials. We will continue working tirelessly to ensure that our vaccines continue to reach citizens in Europe and around the world, to end the pandemic as quickly as possible.”
Novavax is a biotechnology company developing next-generation vaccines for serious infectious diseases. Their COVID-19 vaccine is already under rolling review by EMA in view of a potential market authorisation.
The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company's experience in vaccine development and its production capacity to supply the whole of the EU.
Latest News from
NextGenerationEU: European Commission disburses €237 million in pre-financing to Latvia13/09/2021 10:25:00
The European Commission recently (10 September 2021) disbursed €237 million to Latvia in pre-financing, equivalent to 13% of the country's financial contribution as established in the Council Implementing Decision.
COVID-19: Council adds Uruguay and removes six countries from the list of countries for which travel restrictions should be lifted10/09/2021 15:25:00
Following a review under the recommendation on the gradual lifting of the temporary restrictions on non-essential travel into the EU, the Council updated the list of countries, special administrative regions and other entities and territorial authorities for which travel restrictions should be lifted.
Strengthened EU export control rules kick in10/09/2021 13:25:00
The EU is strengthening its ability to respond to new security risks and emerging technologies.
NextGenerationEU: European Commission disburses €157 million in pre-financing to Cyprus10/09/2021 11:33:00
The European Commission yesterday disbursed €157 million to Cyprus in pre-financing, equivalent to 13% of the grant and loan component of the country's financial allocation.
2021 Strategic Foresight Report: Enhancing the EU's long-term capacity and freedom to act10/09/2021 09:25:00
The Commission recently (08 September 2021) adopted its second annual Strategic Foresight Report – “The EU's capacity and freedom to act”*.
EU reinforces its leading position in global agri-food trade09/09/2021 16:33:00
2020 marked another improvement in the EU's leading position among the world's biggest exporters of agri-food products. On the import side, the EU has become the third largest importer after the United States and China, according to a report published yesterday.
European Citizens' Initiative: Commission decides to register new citizens' initiative09/09/2021 15:25:00
The European Commission yesterday decided to register a European Citizens' Initiative entitled ‘Ensuring Common Commercial Policy conformity with EU Treaties and compliance with international law'.
Council gives final go-ahead to seven-year funding for accession partners09/09/2021 13:25:00
Member states yesterday gave the final green light to almost 14.2 billion euro of pre-accession financial assistance for the period 2021–2027 in favour of the Republic of Albania, Bosnia and Herzegovina, Kosovo*, Montenegro, the Republic of North Macedonia, the Republic of Serbia and the Republic of Turkey.